Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders
Fortuna announces today the closing of its
"We are excited to welcome
- For the first time, patients suffering from neurotrauma or neurodegeneration will be able to be treated with their own neural stem cells providing functional integration without immunosuppression or ethical issues (the technology uses no fetal, embryonic-like, or other ethically challenging processes).
- The manufacturing of autologous drNPCs is accomplished with a rapid, high throughput, and fully automated process, which does not involve genetic engineering, animal components, or staged pluripotency.
In conjunction with the investment by
Dr. Dunlop has been with Amgen since 2016 and is leading efforts focused on neurodegenerative diseases, migraine and analgesia. Previously he was VP and Head of the Neuroscience Innovative Medicine Unit at AstraZeneca, leading discovery and early development efforts. Prior to joining AstraZeneca, Dr. Dunlop was Executive Director in the Neuroscience Research Unit at Pfizer with responsibility for the preclinical portfolios in Neurology and Psychiatry. He joined Pfizer as part of the Wyeth integration and at Wyeth held roles as head of Psychiatry and Acting Head of Neuroscience. Trained as a neuropharmacologist, his current research interests include the role of proteostasis mechanisms, innate immunity and mitochondrial dysfunction in neurodegenerative diseases such as Alzheimer's, Parkinson's disease and ALS, and on the emerging genetics of brain disorders. He is a member of the
"This investment in
About
About Macnguyen Family Office Curtis Macnguyen is founder and CIO of a
About Salamander Invest Salamander Invest is a single purpose investment company established by Norwegian family offices and institutional investors to support the clinical development and commercialization of
About Fortuna Fix
Media contact
Dr. Masha Legris Stromme
Email: [email protected]
www.fortunafix.com
View original content with multimedia:http://www.prnewswire.com/news-releases/fortuna-fix-announces-series-b-financing-adding-amgen-ventures-and-macnguyen-family-office-as-shareholders-300551592.html
SOURCE Fortuna Fix
Democrat Jones talks health care in Senate campaign stop
CALLS FOR THE SENATE TO REPEAL OBAMACARE’S INDIVIDUAL MANDATE IN ITS TAX REFORM BILL, KEEPING MORE MONEY IN THE POCKETBOOKS OF MILLIONS OF HARDWORKING AMERICANS
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News